HDAC inhibitor (intravesical)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HDAC inhibitor (intravesical), covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents [Phase 1]